Náttúrufræðingurinn - 2011, Síða 46

Náttúrufræðingurinn
98
Zeni, O., Salvemini, F., Di Pietro, R., Buonincontri, D., Komulainen, H., 22.
Romano, M. & Scarfi, M.R. 2004. Induction of oxidative stress in
murine cell lines by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5h)-
furanone (mx). Toxicology Letters 147. 79–85.
Runger, T.M. & Kappes, U.P. 2008. Mechanisms of mutation formation 23.
with long-wave ultraviolet light (uva). Photodermatology Photoimmu-
nology & Photomedicine 24. 2–10.
Ichihashi, M., Ueda, M., Budiyanto, A., Bito, T., Oka, M., Fukunaga, M., 24.
Tsuru, K. & Horikawa, T. 2003. Uv-induced skin damage. Toxicology 189.
21–39.
Sage, E. 1993. Distribution and repair of photolesions in DNA – genetic 25.
consequences and the role of sequence context. Photochemistry and
Photobiology 57. 163–174.
Gorner, H. 1994. Photochemistry of DNA and related biomolecules – 26.
quantum yields and consequences of photoionization. Journal of Photo-
chemistry and Photobiology B-Biology 26. 117–139.
Rochette, P.J., Therrien, J.P., Drouin, R., Perdiz, D., Bastien, N., Drobetsky, 27.
E.A. & Sage, E. 2003. Uva-induced cyclobutane pyrimidine dimers form
predominantly at thymine-thymine dipyrimidines and correlate with the
mutation spectrum in rodent cells. Nucleic Acids Research 31. 2786–2794.
Daya-Grosjean, L. & Sarasin, A. 2005. The role of uv induced lesions in 28.
skin carcinogenesis: An overview of oncogene and tumor suppressor
gene modifications in xeroderma pigmentosum skin tumors. Mutation
Research-Fundamental and Molecular Mechanisms of Mutagenesis 571.
43–56.
Cardis, E., Howe, G., Ron, E., Bebeshko, V., Bogdanova, T., Bouville, A., 29.
Carr, Z., Chumak, V., Davis, S., Demidchik, Y., Drozdovitch, V., Gentner,
N., Gudzenko, N., Hatch, M., Ivanov, V., Jacob, P., Kapitonova, E.,
Kenigsberg, Y., Kesminiene, A., Kopecky, K.J., Kryuchkov, V., Loos, A.,
Pinchera, A., Reiners, C., Repacholi, M., Shibata, Y., Shore, R.E., Thomas,
G., Tirmarche, M., Yamashita, S. & Zvonova, I. 2006. Cancer consequenc-
es of the Chernobyl accident: 20 years on. Journal of Radiological Protec-
tion 26. 127–140.
Boice, J.D. 2006. Thyroid disease 60 years after hiroshima and 20 years 30.
after Chernobyl. Jama-Journal of the American Medical Association 295.
1060–1062.
Goodman, M.T., Cologne, J.B., Moriwaki, H., Vaeth, M. & Mabuchi, K. 31.
1997. Risk factors for primary breast cancer in Japan: 8-year follow-up of
atomic bomb survivors. Preventive Medicine 26. 144–153.
Land, C.E. 1995. Studies of cancer and radiation-dose among atomic-32.
bomb survivors – the example of breast-cancer. Jama-Journal of the
American Medical Association 274. 402–407.
Nakachi, K., Hayashi, T., Hamatani, K., Eguchi, H. & Kusunoki, Y. 2008. 33.
Sixty years of follow-up of Hiroshima and Nagasaki survivors: Current
progress in molecular epidemiology studies. 109–117.
Imaizumi, M., Usa, T., Tominaga, T., Neriishi, K., Akahoshi, M., Nakashi-34.
ma, E., Ashizawa, K., Hida, A., Soda, M., Fujiwara, S., Yamada, M., Ejima,
E., Yokoyama, N., Okubo, M., Sugino, K., Suzuki, G., Maeda, R., Naga-
taki, S. & Eguchi, K. 2006. Radiation dose-response relationships for thy-
roid nodules and autoimmune thyroid diseases in Hiroshima and Naga-
saki atomic bomb survivors 55–58 years after radiation exposure.
Jama-Journal of the American Medical Association 295. 1011–1022.
Preston, D.L., Ron, E., Tokuoka, S., Funamoto, S., Nishi, N., Soda, M., 35.
Mabuchi, K. & Kodama, K. 2007. Solid cancer incidence in atomic bomb
survivors: 1958–1998. Radiation Research 168. 1–64.
Tanaka, K., Endo, S., Imanaka, T., Shizuma, K., Hasai, H. & Hoshi, M. 36.
2008. Skin dose from neutron-activated soil for early entrants following
the a-bomb detonation in Hiroshima: Contribution from beta and gam-
ma rays. Radiation and Environmental Biophysics 47. 323–330.
Richardson, D.B. 2009. Exposure to ionizing radiation in adulthood and 37.
thyroid cancer incidence. Epidemiology 20. 181–187.
Aleksakhin, R.M., Sanzharova, N.I. & Fesenko, S.V. 2006. Radioecology 38.
and the accident at the Chernobyl nuclear power plant. Atomic Energy
100. 257–263.
Bouville, A., Likhtarev, I.A., Kovgan, L.N., Minenko, V.F., Shinkarev, S.M. 39.
& Drozdovitch, V.V. 2007. Radiation dosimetry for highly contaminated
Belarusian, Russian and Ukrainian populations, and for less contami-
nated populations in Europe. Bls. 487–501.
Fucic, A., Brunborg, G., Lasan, R., Jezek, D., Knudsen, L.E. & Merlof, D.F. 40.
2008. Genomic damage in children accidentally exposed to ionizing
radiation: A review of the literature. Mutation Research-Reviews in
Mutation Research 658. 111–123.
Marciulioniene, D., Kiponas, D., Luksiene, B. & Gaina, V. 2005. Effects of 41.
cs-137 low level exposure (internal and external) doses on plants. Nuk-
leonika 50. 161–166.
Verger, P., Catelinois, O., Tirmarche, M., Cherie-Challine, L., Pirard, P., 42.
Colonna, M. & Hubert, P. 2003. Thyroid cancers in France and the Cher-
nobyl accident: Risk assessment and recommendations for improving
epidemiological knowledge. Health Physics 85. 323–329.
Woraul, B.V., Kundiyev, Y.I., Sergiyenko, N.M., Chumak, V.V., Vitte, P.M., 43.
Medvedovsky, C., Bakhanova, E.V., Junk, A.K., Kyrychenko, O.Y., Musi-
jachenko, N.V., Shylo, S.A., Vitte, O.P., Xu, S., Xue, X. & Shore, R.E. 2007.
Cataracts among Chernobyl clean-up workers: Implications regarding
permissible eye exposures. Radiation Research 167. 233–243.
Cardis, E., Gilbert, E.S., Carpenter, L., Howe, G., Kato, I., Armstrong, 44.
B.K., Beral, V., Cowper, G., Douglas, A., Fix, J., Fry, S.A., Kaldor, J., Lave,
C., Salmon, L., Smith, P.G., Voelz, G.L. & Wiggs, L.D. 1995. Effects of
low-doses and low-dose rates of external ionizing-radiation – cancer
mortality among nuclear industry workers in 3 countries. Radiation
Research 142. 117–132.
Vrijheid, M., Cardis, E., Blettner, M., Gilbert, E., Hakama, M., Hill, C., 45.
Howe, G., Kaldor, J., Muirhead, C.R., Schubauer-Berigan, M., Yoshimura,
T., Ahn, Y.O., Ashmore, P., Auvinen, A., Bae, J.M., Engels, H., Gulis, G.,
Habib, R.R., Hosoda, Y., Kurtinaitis, J., Malker, H., Moser, M., Rodrigu-
ez-Artalejo, E., Rogel, A., Tardy, H., Telle-Lamberton, M., Turai, I., Usel,
M. & Veress, K. 2007. The 15-country collaborative study of cancer risk
among radiation workers in the nuclear industry: Design, epidemiologi-
cal methods and descriptive results. Radiation Research 167. 361–379.
Pilinskaya, M.A., Dibskij, S.S., Znajevskaja, I.A. & Dibskaja, E.B. 1995. 46.
Dynamic of mutation process in peripheral blood lymphocytes after
long term exposure to low doses of ionizing radiation. Citologia i Gene-
tika 29. 56–61.
The continental scale of the Chernobyl accident 2007. 47. Í: UNEP/GRID-
Arendal Maps and Graphics Library. http://maps.grida.no/go/graph-
ic/the-continental-scale-of-the-chernobyl-accident (sótt 5. júlí 2011).
Tronko, M., Bogdanova, T., Likahatarev, I., Komisarenko, I., Kovalenko, 48.
A., Epstein, O., Tereshchenko, V., Shpak, V. & Gulak, L. 2007. Thyroid
gland and radiation (fundamental and applied aspects): 20 years after
the Chernobyl accident. Int. Congress. Ser. 1299. 46–53.
Ronckers, C.M., Erdmann, C.A. & Land, C.E. 2005. Radiation and breast 49.
cancer: A review of current evidence. Breast Cancer Research 7. 21–32.
Padovani, L., Caporossi, D., Tedeschi, B., Vernole, P., Nicoletti, B. & 50.
Mauro, F. 1993. Cytogenetic study in lymphocytes from children
exposed to ionizing-radiation after the Chernobyl accident. Mutation
Research 319. 55–60.
Padovani, L., Stronati, L., Mauro, F., Testa, A., Appolloni, M., Anzidei, P., 51.
Caporossi, D., Tedeschi, B. & Vernole, P. 1997. Cytogenetic effects in
lymphocytes from children exposed to radiation fall-out after the Cher-
nobyl accident. Mutation Research-Genetic Toxicology and Environmen-
tal Mutagenesis 395. 249–254.
Barale, R. Gemignani, F., Morizzo, C., Lori, A., Rossi, A., Antonelli, A., Di 52.
Pretoro, G., Panasiuk, G. & Ballardin, M. 1998. Cytogenetic damage in
lymphocytes of healthy and thyroid tumor-affected children from the
gomel region (Belarus). Mutation Research 405. 89–95.
Preston, D.L., Shimizu, Y., Pierce, D.A., Suyama, A. & Mabuchi, K. 2003. 53.
Studies of mortality of atomic bomb survivors. Report 13: Solid cancer
and noncancer disease mortality: 1950–1997. Radiation Research 160.
381–407.
Moysich, K.B., Menezes, R.J. & Michalek, A.M. 2002. Chernobyl-related 54.
ionising radiation exposure and cancer risk: An epidemiological review.
Lancet Oncology 3. 269–279.
Tubiana, M., Feinendegen, L.E., Yang, C.C. & Kaminski, J.M. 2009. The 55.
linear no-threshold relationship is inconsistent with radiation biologic
and experimental data. Radiology 251. 13–22.
Descatha, A., Jenabian, A., Conso, F. & Ameille, J. 2005. Occupational 56.
exposures and haematological malignancies: Overview on human
recent data. Cancer Causes & Control 16. 939–953.
Wing, S., Richardson, D., Wolf, S., Mihlan, G., Crawford-Brown, D. & 57.
Wood, J. 2000. A case control study of multiple myeloma at four nuclear
facilities. Annals of Epidemiology 10. 144–153.
West, R.R., Stafford, D.A., Farrow, A. & Jacobs, A. 1995. Occupational 58.
and environmental exposures and myelodysplasia – a case-control study.
Leukemia Research 19. 127–139.
Cardis, E. 2007. Current status and epidemiological research needs for 59.
achieving a better understanding of the consequences of the Chernobyl
accident. Bls. 542–546.
Jackson, S.P. 2009. The DNA-damage response: New molecular insights 60.
and new approaches to cancer therapy. Bls. 483–494.
Linet, M.S., Kim, K.P. & Rajaraman, P. 2009. Children’s exposure to diag-61.
nostic medical radiation and cancer risk: Epidemiologic and dosimetric
considerations. Pediatric Radiology 39. S4–S26.
Green, D.M., Kawashima, T., Stovall, M., Leisenring, W., Sklar, C.A., 62.
Mertens, A.C., Donaldson, S.S., Byrne, J. & Robison, L.L. 2009. Fertility
of female survivors of childhood cancer: A report from the childhood
cancer survivor study. Journal of Clinical Oncology 27. 2677–2685.
Adams, M.J., Hardenbergh, P.H., Constine, L.S. & Lipshultz, S.E. 2003. 63.
Radiation-associated cardiovascular disease. Critical Reviews in Oncol-
ogy Hematology 45. 55–75.
Rutqvist, L.E. & Johansson, H. 1990. Mortality by laterality of the pri-64.
mary tumor among 55,000 breast-cancer patients from the Swedish
Cancer Registry. British Journal of Cancer 61. 866–868.
Taylor, C.W., Mcgale, P. & Darby, S.C. 2006. Cardiac risks of breast-cancer 65.
radiotherapy: A contemporary view. Clinical Oncology 18. 236–246.
Schoder, H. & Larson, S.M. 2004. Positron emission tomography for 66.
prostate, bladder, and renal cancer. Seminars in Nuclear Medicine 34.
274–292.
Wadsak, W. & Mitterhauser, M. 2010. Basics and principles of radiophar-67.
maceuticals for pet/ct. European Journal of Radiology 73. 461–469.
81_2#profork070711.indd 98 7/8/11 7:42:01 AM